As World Immunization Week kicks off today, childhood vaccination remains among the most cost-effective uses of health spending. Significant progress has been made to expand global vaccine coverage. Yet, rates remain inequitable and highly variable—within countries but also across those in the same ...

How can we ensure that medical countermeasures—such as diagnostics and vaccines—are ready to go at local, national, and global levels when the next pandemic emerges? Amanda Glassman speaks with Dr. Amadou Alpha Sall of Institut Pasteur of Dakar and Dr. Rachel Glennerster of the University of Chicago...

During this long period of leadership stability, there has been enormous growth in Gavi’s funding and staffing, even through the stormy waters of COVID-19, with enough vaccines delivered to legitimately claim millions of lives saved. Dr. Pate will arrive with a strong financial base, the ability to ...

On this episode of Pandemic Proof, Dr. Ayoade Alakija, the World Health Organization’s Special Envoy for the Access to COVID-19 Tools Accelerator (ACT-A) and co-chair of the African Union’s African Vaccine Delivery Alliance, joins Javier Guzman to discuss global cooperation during health emergencies...

Countries in Latin America were hit especially hard by the COVID-19 pandemic. On this episode of Pandemic Proof, Amanda Glassman welcomes Dr. Jarbas Barbosa da Silva Jr., candidate for Director of the Pan American Health Organization (PAHO), to the podcast to discuss impacts and lessons learned. Tog...

If there remains a need, and a clinical and economic rationale, for COVID-19 vaccination, why is vaccine inequity so persistent over time?

Get ready for Pandemic Proof, a new podcast from the Center for Global Development. Hosted by CGD's Amanda Glassman and Javier Guzman and featuring guests from around the world, Pandemic Proof will confront weaknesses in the global architecture for pandemic preparedness and response, and explore pol...

Monkeypox has been around for decades, but it has been low priority for global and public health, despite a notable reemergence of the disease in West and Central Africa in 2017. Now, as the virus reaches 35 countries outside the West and Central African regions, the disease’s current dynamics are s...